Skip to main content
. 2021 Sep 24;9(6):100438. doi: 10.1016/j.esxm.2021.100438

Table 1.

Comparisons between the subjects without and with different types of comorbid PE in the ED group

Variables Subjects without PE (n = 1291) Subjects with lifelong PE (n = 77) Subjects with acquired PE (n = 341) Subjects with Probable PE (n = 184) P value
Age, y 54.1 ± 13 (20–88) 51.2 ± 12.8 (25–70) 51 ± 11.5 (20–75) 52.3 ± 12 (24–75) P <.001
Obesity* (BMI ≥ 27 kg/m2) 30.1% (389) 23.4% (18) 27.6% (95) 27.7% (51) No significance
Diabetes mellitus 29.4% (379) 23.4% (18) 17.6% (60) 15.2% (28) P <.001
Hypertension 33.0% (426) 28.6% (22) 27.6% (94) 31.0% (57) No significance
Dyslipidemia 50.6% (653) 53.2% (41) 44.9% (154) 47.8% (88) No significance
MACE 7.2% (93) 9.1% (7) 5.9% (20) 8.2% (15) No significance
Hypogonadism* 27.4% (283) 23.3% (14) 23.8% (62) 22.6% (33) No significance
ED duration, y 2.7 ± 3.8 (0.3–40) 3.9 ± 5.2 (0.3–30) 3.2 ± 4.1 (0.3–30) 2.8 ± 3.7 (0.3–30) P <.05
Total SHIM score 10.7 ± 5.9 (1–25) 9.3 ± 4.9 (1–23) 9.5 ± 4.9 (1–25) 11.6 ± 5.6 (1–23) P <.001
ED severity
 Normal 3.8% (49) 1.3% (1) 0.9% (3) 3.8% (7) P <.001
 Mild 13.5% (174) 6.5% (5) 7.6% (26) 15.8% (29)
 Mild to moderate 26.6% (344) 24.7% (19) 24.0% (82) 32.1% (59)
 Moderate 22.2% (286) 28.6% (22) 29.2% (99) 23.4% (43)
 Severe 33.9% (438) 39.0% (30) 38.4% (131) 25.0% (46)

Abbreviations: BMI = body mass index, ED = erectile dysfunction, MACE = major adverse cardiovascular events, PE = premature ejaculation, SHIM = Sexual Health Inventory for Men,

Hypogonadism is defined as a serum total testosterone level below 348 ng/dL.